Article Details
Retrieved on: 2021-04-19 12:45:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Any participants who develop symptoms will be treated with Regeneron's monoclonal antibody treatment. The second phase of the study, starting in ...
Article found on: www.biopharma-reporter.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here